Pharma Journalist - Page 124 of 834 -

Solid Biosciences Receives FDA IND Clearance for Dual Route Gene Therapy in Friedreich’s Ataxia

FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application

Amgen’s IMDYLLTRA Granted Conditional Approval for Small Cell Lung Cancer in UK

RINVOQ (Upadacitinib) Receives Its Sixth U.S. FDA Approval

HOOKIPA announces strategic collaboration and license agreement with Roche to develop novel arenaviral immunotherapy for KRAS-mutated cancers

Corium and Gurnet Point Capital Announce Manufacturing Business Acquisition and a $100 Million Neuroscience Therapeutics Investment by Webster Equity Partners, Establishing Two Independent Growth Companies

Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk Pharma to Develop First-in-Class Celiac Disease Therapy

AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX

AbbVie Acquires DJS Antibodies, Further Strengthening Immunology Pipeline

FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for Adults

Catalent Expands Biologics Analytical Capabilities with New Laboratories at Center of Excellence in Kansas City, Missouri

Zymeworks To Host Conference Call on Exclusive Licensing Agreement of Zanidatamab

Telesis Bio and Cellibre Announce Collaboration to Optimize Development of Future BioXp DBC instrument